Adient Medical
Pearland, US · Founded 2012 · Delaware corporation · 4 known investors
Founders & leadership
ME
Mitchell EggersExecutive
Board
MH
Michael HoganBoard director
RT
Robert TucciBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$18.2M disclosed across 4 rounds · 2016–2022
▶$14.3MraisedOct 2022 · 40 investors · BiotechnologyRule 506(b)
▶$14.3MraisedOct 2022 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert TucciDirector
- Robert MitchellDirector
- Michael HoganDirector
- Mitchell EggersExecutive Officer, Director
- Offering amount
- $14.3M
- Amount sold
- $14.3M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$711KraisedFeb 2021 · 19 investors · BiotechnologyRule 506(b)
▶$711KraisedFeb 2021 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael HoganDirector
- Robert TucciDirector
- Robert MitchellDirector
- Mitchell EggersExecutive Officer, Director
- Offering amount
- $2.2M
- Amount sold
- $711K
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedJul 2017 · 20 investors · BiotechnologyRule 506(b)
▶$1.7MraisedJul 2017 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL HOGANDirector
- ROBERT TUCCIDirector
- MITCHELL D. EGGERSExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $1.7M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1.5MraisedJul 2016 · 20 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJul 2016 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael HoganDirector
- Mitchell EggersExecutive Officer, Director
- Robert TucciDirector
- Offering amount
- $1.8M
- Amount sold
- $1.5M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
AngioDynamics9 shared keywordsAngioDynamics develops and manufactures medical devices aimed at treating serious diseases and improving patient outcomes. Founded in 1988, the company serves healthcare professionals and operates globally across North America, Europe, the Middle East, and South America.
Boston Scientific7 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Entac Medical, Inc.6 shared keywordsEntac Medical develops wearable devices that apply predictive analytics and AI to biological acoustic signals to predict patient adverse events, aiming to improve patient outcomes and reduce hospital readmissions and cost of care. It serves the healthcare sector as a digital health company.
Companies competing with Adient Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who are Adient Medical's investors?
- Adient Medical's investors include Broadview Ventures, Houston Angel Network, Texas HALO Fund, Texas Ventures.
- How much funding has Adient Medical raised?
- Adient Medical has disclosed $18.2M raised across 4 rounds.
- Where is Adient Medical headquartered?
- Adient Medical is headquartered in Pearland, US.